Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.69 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9492603 | 0.92 | ALDH1A1 (0.76) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL10971124 | 0.88 | ALDH1A1 (0.70) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL18798610 | 0.86 | ALDH1A1 (0.69) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL15923520 | 0.85 | ALDH1A1 (0.67) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL9170322 | 0.85 | ALDH1A1 (0.67) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL9168088 | 0.85 | ALDH1A1 (0.67) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL5507075 | 0.85 | ALDH1A1 (0.70) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL27182229 | 0.85 | PKM (0.64) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL13602366 | 0.84 | ALDH1A1 (0.70) | ALDH1A1HPGDPOLBHDAC1HDAC3 | |
| SCHEMBL9321269 | 0.84 | SMN1; SMN2 (0.67) | HDAC1HDAC3SMN1; SMN2L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100357295-C | Macrocyclic pyrimidines, their production and use as pharmaceutical agents | SCHERING AG (DE) | 2007-12-26 | — | — | CN | disclosed |
| US-7312225-B2 | Macrocyclic pyrimidines, their production and use as pharmaceutical agents | BAYER SCHERING PHARMA AG (DE) | 2007-12-25 | — | — | US | disclosed |
| US-7312225-B2 | Macrocyclic pyrimidines, their production and use as pharmaceutical agents | BAYER SCHERING PHARMA AG (DE) | 2007-12-25 | — | — | US | disclosed |
| US-7312225-B2 | Macrocyclic pyrimidines, their production and use as pharmaceutical agents | BAYER SCHERING PHARMA AG (DE) | 2007-12-25 | — | — | US | disclosed |
| EP-1530574-B1 | MACROCYCLIC PYRIMIDINES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS MEDICAMENTS | SCHERING AG (DE) | 2006-11-22 | — | — | EP | disclosed |
| CN-1675225-A | Macrocyclic pyrimidine compounds, process for their preparation and their use as pharmaceuticals | SCHERING AG (DE) | 2005-09-28 | — | — | CN | disclosed |
| US-20040209895-A1 | inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases | SCHERING AG (DE) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209895-A1 | inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases | CCNK, CDK2, CDK1 | ALDH1A1 2715/4885HPGD 1158/4885POLB 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.